BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 14, 2004
View Archived Issues
Adprotech Being Acquired By Inflazyme In C$20M Deal
LONDON - Last week, shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9 million) in shares. (BioWorld International)
Read More
EuropaBio Probes Fairness To Biotech In New EU Rules
Read More
Interfering RNA Libraries Might Boost Mammalian Gene Insight
Read More
Start-up Opsona Focused On Toll-Like Receptor Signaling
Read More
Although Cleared For Planting, Bayer Ditching UK Maize Plans
Read More
Other News To Note
Read More